Detailed price information for Exact Sciences Cor (EXAS-Q) from The Globe and Mail including charting and trades.

The fund outperformed its benchmark and peers for the final quarter and full year 2024, driven by positive stock selection.

Generali Asset Management SPA SGR has purchased 11,358 shares of Regeneron Pharmaceuticals, valued at approximately $8.1 ...

Immuneering (IMRX) announced that Igor Matushansky, MD, PhD, has joined the company as Chief Medical Officer. In this role, he will direct ...